AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-213590558/major-european-regulatory-milestone.html" title="Facts and information about Major European regulatory milestone in cardiovascular protection for Micardis (telmisartan): Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients.">Major European regulatory milestone in cardiovascular protection for Micardis (telmisartan): Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Major European regulatory milestone in cardiovascular protection for Micardis (telmisartan): Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients.
The European Commission has approved Boehringer Ingelheim's Micardis (telmisartan) for the reduction of cardiovascular morbidity in patients with manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or type 2 diabetes mellitus with documented target organ damage. Micardis is the first treatment in its class to be …
Related articles from newspapers, magazines, journals, and more
-
- Major European regulatory milestone in cardiovascular protection for Micardis...
-
News wire article from: Chemical Business Newsbase
November 27, 2009
700+ words
